Patient characteristics
| . | All patients . |
|---|---|
| No. of patients | 103 |
| Female | 44 (43%) |
| Age at transplant, median (range), y | 11.0 (0.5-18.6) |
| Renal function, median (range), mL/min per 1.73 m2 | 140 (69.3-140) |
| Cell source | |
| Bone marrow | 44 (43%) |
| Cord blood | 58 (56%) |
| Peripheral blood | 1 (1%) |
| Donor type | |
| Unrelated | 80 (78%) |
| Related | 23 (22%) |
| Diagnosis type | |
| ALL | 45 (44%) |
| AML | 38 (37%) |
| Other | 20 (19%) |
| Year of transplantation | |
| 2011-2013 | 16 (15%) |
| 2014-2016 | 45 (44%) |
| 2017-2019 | 42 (41%) |
| No. of transplant | |
| First | 99 (96%) |
| Second | 3 (3%) |
| Third | 1 (1%) |
| ATG | |
| Yes | 46 (45%) |
| No | 57 (55%) |
| . | All patients . |
|---|---|
| No. of patients | 103 |
| Female | 44 (43%) |
| Age at transplant, median (range), y | 11.0 (0.5-18.6) |
| Renal function, median (range), mL/min per 1.73 m2 | 140 (69.3-140) |
| Cell source | |
| Bone marrow | 44 (43%) |
| Cord blood | 58 (56%) |
| Peripheral blood | 1 (1%) |
| Donor type | |
| Unrelated | 80 (78%) |
| Related | 23 (22%) |
| Diagnosis type | |
| ALL | 45 (44%) |
| AML | 38 (37%) |
| Other | 20 (19%) |
| Year of transplantation | |
| 2011-2013 | 16 (15%) |
| 2014-2016 | 45 (44%) |
| 2017-2019 | 42 (41%) |
| No. of transplant | |
| First | 99 (96%) |
| Second | 3 (3%) |
| Third | 1 (1%) |
| ATG | |
| Yes | 46 (45%) |
| No | 57 (55%) |